Related references
Note: Only part of the references are listed.Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
Timothy R. Fouts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development
George K. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
IgG4 subclass antibodies impair antitumor immunity in melanoma
Panagiotis Karagiannis et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies
Constanze Hess et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A novel assay for detecting virus-specific antibodies triggering activation of Feγ receptors
Eugenia Corrales-Aguilar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus
Viktoria Stab et al.
PLOS ONE (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
Marit J. van Gils et al.
VIROLOGY (2013)
How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?
Per Johan Klasse et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs
Carolin M. Oefner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
Risk of Immunodeficiency Virus Infection May Increase with Vaccine-Induced Immune Response
Matthias Tenbusch et al.
JOURNAL OF VIROLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting Antibody Responses to the Membrane Proximal External Region of the Envelope Glycoprotein of Human Immunodeficiency Virus
Donatien Kamdem Toukam et al.
PLOS ONE (2012)
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Fc-Glycosylation of IgG1 is Modulated by B-cell Stimuli
Jun Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Immunological mechanisms of vaccination
Bali Pulendran et al.
NATURE IMMUNOLOGY (2011)
A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells
Michael A. Eller et al.
PLOS ONE (2011)
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
Larry Zeitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
B cell responses to HIV-1 infection and vaccination: pathways to preventing infection
Barton F. Haynes et al.
TRENDS IN MOLECULAR MEDICINE (2011)
HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals
Michael Melmer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes
A. ISHIZAKA et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Regulation of CD4 T-cell receptor diversity by vaccine adjuvants
Christina K. Baumgartner et al.
IMMUNOLOGY (2010)
Augmented Antibody Response with Premature Germinal Center Regression in CD40L Transgenic Mice
Yusuke Kishi et al.
JOURNAL OF IMMUNOLOGY (2010)
Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12
Donald N. Forthal et al.
JOURNAL OF IMMUNOLOGY (2010)
Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity
Leopold Kong et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
Falk Nimmerjahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection
Mattia Bonsignori et al.
JOURNAL OF IMMUNOLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo
Kaustuv Banerjee et al.
VIROLOGY (2009)
Signalling through C-type lectin receptors: shaping immune responses
Teunis B. H. Geijtenbeek et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins
L. Renee Ruhaak et al.
ANALYTICAL CHEMISTRY (2008)
Correlates of vaccine-induced immunity
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2008)
Selective CD4+ T cell help for antibody responses to a large viral pathogen:: Deterministic linkage of specificities
Alessandro Sette et al.
IMMUNITY (2008)
In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120
Maria Luisa Visciano et al.
VIROLOGY (2008)
HIV vaccine development in the aftermath of the STEP study:: Re-focus on occult HIV infection?
Klaus Ueberla
PLOS PATHOGENS (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Denise L. Kothe et al.
VIROLOGY (2007)
Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality
Bernard J. Scallon et al.
MOLECULAR IMMUNOLOGY (2007)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and CHIV-1 primary viruses
Hua-Xin Liao et al.
VIROLOGY (2006)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
Early events of electroporation-mediated intramuscular DNA vaccination potentiate Thi-directed immune responses
E Gronevik et al.
JOURNAL OF GENE MEDICINE (2005)
FcγRIV:: A novel FcR with distinct IgG subclass specificity
F Nimmerjahn et al.
IMMUNITY (2005)
Innate IL-10 promotes the induction of Th2 responses with plasmid DNA expressing HIV gp120
LM Daly et al.
VACCINE (2005)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin
XZ Yang et al.
JOURNAL OF VIROLOGY (2002)
Short-circuiting long-lived humoral immunity by the heightened engagement of CD40
LD Erickson et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants
D Markine-Goriaynoff et al.
JOURNAL OF VIROLOGY (2002)
Expression of GnTIII in a recombinant anti-CD20 CHO production cell line:: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FcγRIII
J Davies et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus:: Implications for the safety of lentiviral vectors
R Wagner et al.
HUMAN GENE THERAPY (2000)
Share Paper
